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Abstract
Objectives: The aim of this systematic review was to evaluate studies which
employed routine and cohort data sets to understand inequalities in dementia care
pathways.
Methods: We identified 27 research papers using routine data sets to investigate
inequalities in dementia care pathways through electronic and grey literature
searches. Papers were independently assessed by two reviewers for inclusion based
on defined criteria. Included papers were quality rated using the National Institutes
of Health Quality Assessment Tool for Observational Cohort and Cross‐Sectional
Studies. Data was extracted based on stage(s) in dementia care pathway and socio‐
economic factors investigated.
Results: Inequalities were noted across dementia care pathways. Socio‐economic
and protected characteristics were shown to impact the likelihood of people with
dementia moving into institutional nursing care, the quality and consistency of their
treatment, need for emergency and urgent healthcare, the rate of illness progres-
sion and their long‐term survival. Research was often disparate ignoring the mul-
tiple parts of the dementia care pathway, or the impact of specific factors across
multiple stages.
Conclusions:Our study highlights issues in dementia care pathways based on socio‐
economic or protected characteristics. Equitable service provision, more culturally
appropriate services, improved health literacy and increased provision for both
early diagnosis and care at home can help narrow the gap in dementia care in-
equalities. There is greater need for research investigating dementia care pathways
as something greater than the sum of its parts; exploring the influence of socio‐
economic factors from a person's entrance into the system and throughout.
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1 | INTRODUCTION
The number of people diagnosed with dementia in the United
Kingdom is set to increase in the next 20 years, which will exacerbate
already strained models of health and social care provision. By 2040,
Wittenberg et al. project the number of people with dementia (PwD)
to double and the reflected cost of care to increase threefold.1
Crucially, the greatest proportional increase is expected to occur
among people who will be diagnosed with severe dementia. Yet staff
and services are already struggling to meet current demand. With
further increases in the number of people with pressing needs, and
their reflected costs, this will likely result in a greater levels of unmet
care needs.2
Currently, there are marked socio‐economic and geographic in-
equalities in the prevalence of dementia, availability of informal care,
access to and use of formal care. Socio‐economic status3–5 and place
of residence6,7 influence access to a diagnosis, and aspects of care,
treatment and the support a PwD may receive. Those most socio‐
economically disadvantaged are more likely to bear the brunt of
these inequalities.
Existing socio‐economic inequalities will exacerbate many cur-
rent unmet needs in those affected by dementia, with post‐diagnostic
care often being underfunded and understaffed.8 People who are
unable to afford their own care will endure worse outcomes relative
to more affluent PwD.4,9 In a time of restricted finances, both indi-
vidually and in the public provision and staffing for dementia care, it
is imperative we better understand inequalities within dementia care
pathways. We must provide evidence to inform policy and applied
change in health and social care for PwD.
Routine data sets in dementia—such as the National Alzheimer's
Coordinating Center in the United States and SveDem in Sweden—
are large databases containing standardised clinical and service
interaction records for PwD. Such registries are developed with the
aim of harnessing data to identify issues in access to, and quality of
care, as a means to improve health and social outcomes. Other
routine data sets, such as those focussing on hospital admissions,
accident and emergency attendances, primary care records and social
care interactions can also be used to uncover a wider picture of care
pathways for PwD.
The aim of this systematic review was to evaluate studies which
employed routine and cohort data sets to understand inequalities in
dementia care pathways. Existing systematic reviews have explored
specific socio‐economic inequalities in dementia care pathways,
including age, ethnicity, gender, deprivation and country of resi-
dence.10–14 However, this is the first to explore how routine data
sets have been used internationally to understand dementia care
pathways, variance in care and inequalities in dementia care path-
ways. With continued restricted government funding for dementia
care and an increase in the number of PwD reliant on state‐funded
care, the use and application of routine data is crucial to understand
where and how inequalities emerge. This knowledge can enable
improved person‐centred care that generates a better quality of life
for PwD and their carers, and attempt to reduce related inequalities
in care.
2 | METHODS
This systematic review was registered on the PROSPERO Interna-
tional prospective register of systematic reviews (ID:
CRD42020162934).
2.1 | Search strategy
We searched the Cochrane Central Register of Controlled Trials,
CINAHL, Google Scholar, MEDLINE, PsycINFO, PubMed and Web of
Science databases up to and including 2020. The search terms ‘de-
mentia’ AND ‘care’ AND ‘routine data’ AND ‘cohort’ were used in
combination. Initially, titles and abstracts of papers were read by JW
and CG, retaining those which were relevant. Discrepancies over
inclusion of papers were discussed between reviewers and an
agreement reached. JW and CG read through the remaining papers in
their entirety, to define against inclusion and exclusion criteria. Any
ambiguity over inclusion of papers was discussed between reviewers
until an agreement was reached.
A search of grey literature and snowballing of references from
the papers already included were used to find further papers meeting
the inclusion criteria.
2.2 | Inclusion criteria
The population used in the studies had to be dementia‐specific and
PwD need to have received a formal diagnosis of dementia. Only
English language papers, published since 01 January 1990, looking at
the use of routine or cohort data to quantitatively explore issues of
Key points
� The first systematic review identifying research using
routine and cohort data sets to explore inequalities in
dementia care pathways
� We highlight inequalities in care pathways for people
with dementia, by socio‐economic factors and protected
characteristics
� There is a greater need for appropriate and equitable
dementia service provision
� Future research needs to encompass a more holistic view
of dementia illness trajectory and the related change in
care needs
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care pathways and care utilisation in people living with dementia and
their family carers were included.
2.3 | Exclusion criteria
Papers published in any language other than English, published
before 01 January 1990, using qualitative research methods, or
quantitative papers not using routine or cohort data were excluded;
reviews of any kind were also discounted. Papers with populations
with no formal dementia diagnosis, non‐dementia study populations
or those with mixed diagnoses, for example, dementia and mild
cognitive impairment were also excluded.
2.4 | Assessment of quality
The National Institutes of Health (NIH) Quality Assessment Tool for
Observational Cohort and Cross‐Sectional Studies was employed in
this review; a 14‐point checklist (see Table 3 footnotes). This tool has
been used as it is a practical and pragmatic method of identifying
potential flaws in the methodology of cohort studies which may in-
crease bias. Such biases can undermine research strength and quality,
casting potential doubt over subsequent results.
2.5 | Data extraction
To process the literature to conduct the data synthesis, the relevant
findings were taken from the final research based on the aims and
objectives of the systematic review. The following information was
taken from each paper: Author name(s), research title, year of pub-
lication, country/countries of study, dementia population/subtype,
socio‐economic analysis in study (if yes, which socio‐economic cate-
gories are included), outcomes and stages(s) in pathway.
2.6 | Data synthesis
A narrative summary of the evidence taken from the final included
papers was conducted. This process involves drawing out specific
findings from quantitative papers when a meta‐analysis is not
feasible.15 From the included papers we looked at: what their find-
ings tell us and what part(s) of the dementia care pathway they
related to—as defined in the four sub‐headings of the results section:
transitions in nursing care (in the United Kingdom, this includes both
residential care homes—which provide support for people with
personal care and provide accommodation—and nursing homes—
which provide personal care, but also have a greater number of
qualified nurses providing specific condition‐related care; e.g., de-
mentia or neurological conditions), anti‐dementia medications, health
and social care interactions, disease progression, mortality and
survival.
3 | RESULTS
3.1 | Search outcomes
We identified 1506 studies via database (n ¼ 1486) and grey liter-
ature searches (n ¼ 20), 796 of which remained once duplicate re-
cords were removed (see Figure 1 for PRISMA flowchart). Screening
of these records based on titles and abstracts led to the exclusion of
583 records; the remaining 113 records were reviewed as full‐text
papers. Sixty‐seven papers were removed leaving a total of 46
studies which met the defined inclusion criteria.
At stage 1, JW and CG reviewed papers on their abstract and
title, agreeing on the continued inclusion/exclusion of 677 of the 796
(85.1%) papers. At stage 2, JW and CG reviewed the remaining 113
papers based on the full‐text, agreeing on the continued inclusion/
exclusion of 74 (64.5%) of the papers.
3.2 | Characteristics of included studies
Table 1 shows the descriptive characteristics of the 46 included
studies. The majority of these studies focused their analysis on one
country, using one set of routine data. However, some analysed data
from multiple routine or cohort data sets, and in some cases,
different registries across a variety of countries. The vast majority of
studies were conducted in the US (13), England/UK (12), or mainland
Europe (29), with one study conducted in Australia, Hong Kong and
Puerto Rico, respectively.
Twenty‐seven studies have highlighted differences or in-
equalities in care and, or outcomes as a result of a protected char-
acteristic—such as age, gender or ethnicity—income or deprivation,
or personal circumstance—such as availability of informal care. These
27 studies go beyond merely stating, for example, the number of
people of each age group, or who were male and female.
Of these 27 studies, seven specifically investigated socio‐eco-
nomic deprivation or geography as factors in care use and quality,
and or health and social outcomes for PwD (see Table 2).
3.3 | Study outcomes/stage in care pathway
Literature investigated various areas of dementia care and support
(transitions to nursing care, anti‐dementia medication, health and
social care interaction, and disease progression, mortality and sur-
vival). Several studies looked at different stages of the care pathway
(i.e., disease progression, medication initiation and mortality), so that
some studies were discussed across different areas.
3.4 | Transitions to nursing care
Nine studies investigated care transitions for PwD, primarily ana-
lysing the significance and degree to which socio‐economic factors
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can influence the probability of moving into nursing care. Being older
was associated with a significantly greater likelihood of admission to
nursing care.7,35,36 Stevnsborg et al.48 used data from three Danish
health registries to demonstrate that the oldest PwD (those aged
70‐79 and ≥80 years vs. to 60‐69 years) were more likely to live in
nursing care when first diagnosed with dementia. Korhonen et al.36
reported the same association between age and institutionalisation
into long‐term care, but discovered it was starker for women
than men.
Gender was as a factor in care transitions in several studies,
revealing differences in the likelihood of transitions to nursing
care. Stevnsborg et al.35 found women were significantly more
likely to be diagnosed with dementia whilst living in nursing care,
and Smith et al.7 discovered that men with dementia were signifi-
cantly less likely to be admitted to nursing care generally. However,
in the final 2 years of life, a greater proportion of men with
dementia had care transitions, with a higher median number of
transitions than women.16 The timing of transitions in disease
progression was also found to differ by gender. Neumann et al.40
found Alzheimer's disease severity to progress at a faster rate for
men, with men being more likely to transition to nursing care if
they had severe Alzheimer's disease. Women, however, were more
likely to be admitted to nursing care with mild Alzheimer's, indicating
they would enter institutional care earlier in their disease
progression.
Knapp et al.35 investigated ethnicity as a factor in care transi-
tions, finding people of Caribbean/African and East/South Asian
ethnicities to be significantly less likely to be admitted to institutional
care (hospital or nursing home). In Denmark, Stevnsborg et al.48
compared native‐born, Western and non‐Western immigrant de-
mentia populations, discovering non‐Western immigrants were
significantly less likely to be living in a nursing home when receiving
their dementia diagnosis.
3.5 | Anti‐dementia medication
Eighteen studies investigated diagnostics and use of anti‐dementia
medications, with nine analysing socio‐economic variables as factors
in likelihood of anti‐dementia drug initiation.
F I GUR E 1 Search strategy
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Socio‐economic deprivation and country of residence were
shown to impact the likelihood of receiving anti‐dementia medica-
tion. Using UK primary care records, Cooper et al.4 found areas of
greatest deprivation had significantly lower rates of anti‐dementia
medication initiation than the most affluent. In the United Kingdom,
there was a stepped‐effect with each quintile from the most affluent
quintile—which had the highest initiation—to the most deprived—
which had the lowest initiation.
Taipale et al.49 discovered that among people with Alzheimer's
disease using acetylcholinesterase inhibitors (AChEI), older people
were at a higher risk of AChEI discontinuation. However, evidence is
somewhat conflicting regarding the impact of age on anti‐dementia
medication initiation. Although Cooper et al.12 found people
aged under 70 years, and ≥80 years were less likely to be prescribed
anti‐dementia medication than people aged 7‐79 years, several
studies illustrate higher initiation for older people.21,48–50
Several studies demonstrated females had an increased proba-
bility of receiving anti‐dementia medications.12,19,21,33 However, the
research available identified mixed evidence of the likelihood of
having these medications discontinued.49,50
Thorpe et al.50 also investigated the impact of ethnicity on
initiation and discontinuation of anti‐dementia medication. Among
Medicare beneficiaries in the United States who were non‐users of
anti‐dementia medications at the beginning, Hispanic people were
significantly more likely to initiate use than any other ethnicity, with
Black and Hispanic ethnicities significantly more likely to have their
anti‐dementia medications discontinued. Being ‘non‐native’ to a
country can also have an impact on the likelihood of receiving
TAB L E 2 Papers analysing socio‐economic deprivation or geography (county of residence) as a potential factor in outcome measures for
people with dementia
Author Year Deprivation type Analysis conducted using socio‐economic variables
Cooper et al.4 2016 Townsend score quintiles;
Country of residence
Initiation of anti‐dementia drugs:
‐Compared to England→ Northern Ireland significantly more, and Wales
significantly less likely initiate anti‐dementia drugs
‐Anti‐dementia drug initiation → greatest in most affluent areas
‐Anti‐dementia drug initiation → reduction with each quintile to most
deprived
Cooper et al.12 2017 Townsend score
quintiles
Prescription prevalence for antipsychotics, hypnotics and anxiolytics:
‐Most deprived areas → lowest prescription prevalence, but not s
significantly so
Korhonen et al.36 2018 Household income quintile Probability of institutional LTC in 8 years before death/end of study:
‐For men, increasing deprivation→ increased institutionalisation in long‐
term care
Pujades‐Rodgriguez
et al.41
2018 Indices of multiple deprivation
quintile
Mortality differences between those with and without dementia:
‐Greater proportion of deaths in deprived areas are of people with
dementia
Sommerlad et al.47 2019 Indices of multiple
deprivation decile
Association of factors with hospital admissions a year after dementia
diagnosis:
‐Greater deprivation → increased risk of emergency admissions and
reduced risk of elective admissions
van de Vorst et al.52 2016 Disposable household
income tertile
1 and 5‐year mortality risk for people with a first hospitalisation or day
clinic visit for dementia:
‐Greater deprivation → increased mortality risk for men and
women‐deprivation and mortality more likely when visiting a day clinic
versus hospital
Verbeek et al.5 2015 Country of residence Risk factors for recent admission to institutional long‐term
nursing care:
‐Higher dependence for activities of daily living → increased move to
long‐term care in all countries
‐Lower caregiver burden → lower admissions to long‐term care all
countries (not Spain)
‐Having an informal carer who was a spouse → less admissions to long‐
term care all countries (not Estonia, France)
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medications. Stevnsborg et al.48 found that Western and non‐
Western immigrants to Denmark were significantly less likely to
receive anti‐dementia medications than people born in Denmark.
3.6 | Health and social care interaction
Of 17 studies exploring health and social care interactions, eight
involved socio‐economic variables. The greater number of socio‐
economic risk factors somebody has, the greater their likelihood of
hospitalisation,44 for example. It was found that PwD living in the
most socio‐economically disadvantaged areas had a significantly
higher risk of emergency hospital admission, and significantly lower
probability of elective admissions.47
Evidence varies on the exact impact that ethnicity can have on
admissions to hospital for PwD.25,35,47 However, the variance in
findings may be reflective of the country in which the studies were
carried out, and their relevant health and social care systems.
Older PwD were at greater risk of hospitalisation.25,35,44 How-
ever, the type of admissions demonstrates that they may be at
greater risk of emergency hospital admissions, but a significantly
reduced risk of both mental health inpatient35 and elective admis-
sions.47 However, among PwD, those who are older (aged ≥80 years)
and younger have a reduced probability of coming into contact with
health and social care services in a more elective capacity. Cooper
et al.12 identified people aged under 70 years as less likely to come
into contact with healthcare—even for annual dementia reviews—and
those aged 80 and over were less likely to receive surgical consul-
tations or weight monitoring checks. Furthermore, Wattmo et al.55
discovered that for PwD, younger people had a longer delay in
accessing home help services.
Care quality can also be impacted by socio‐economic factors.
Connolly et al.20 found people living in the community had greater
quality annual dementia reviews and overall care than those living in
care homes, and Scalmana et al.45 discovered that people with less
education were less likely to access health and social care services.
3.7 | Disease progression, mortality and survival
Nine studies investigated direct outcomes and illness progression for
PwD, with seven studies focussing on socio‐economic factors.
Both age and gender were found to correlate with disease pro-
gression and mortality risk. Older people and men with Alzheimer's
disease transitioned at a faster rate.40 Women and those who were
younger when receiving a dementia diagnosis were shown to have
better survival,6,32 with older people and men at greater risk of
dying.51,52
Greater support is indicative of better survival, long‐term inde-
pendence and condition maintenance among PwD. As well as noting
that less education is associated with poorer survival for PwD, Huang
et al.32 identified living in the community with a caregiver or in
institutional care acted as a protective factor for survival among
people with Alzheimer's disease. Survival was worse for people living
in a nursing home compared to those living at home,6 living in the
community with a caregiver or in institutional care acted as a pro-
tective factor for people with Alzheimer's disease and living with
others and having multiple carers led to a greater likelihood of a PwD
maintaining their dependence at the level at seen at study start.34
Pujades‐Rodriguez et al.41 compared people with and without
dementia in retrospective analyses of mortality records. They illus-
trated PwD were more likely to live in deprived areas. Van de Vorst
et al.51,52 identified mortality risk as significantly higher for PwD
living in the most socio‐economically disadvantaged areas.
3.8 | Study quality
Using the NIH Quality Assessment Tool for Observational Cohort
and Cross‐Sectional Studies, some of the 14‐points used to assess
quality were not applicable (Table 3) and so had a maximum potential
score of 10 or 11. One paper received a quality rating of 5 (out of 10),
but the remainder received a rating of between 7 and 10. Thus, the
studies included in this review are of moderate to high quality. As a
whole, they were clear in their objectives and findings and tended to
describe and deliver robust research methods.
4 | DISCUSSION
This is the first systematic review evaluating the use of routine and
cohort data sets to investigate inequalities in dementia care path-
ways. Findings from this review highlight the advantage of using
national longitudinal databases to explore inequalities in dementia
care across the globe, highlighting numerous gaps and current in-
equalities in care which need to be addressed.
The most socio‐economically deprived areas have higher rates of
undiagnosed dementia.56 Deprivation can be reflective of wider, so-
cial and structural factors, such as income, employment, housing and
transport. GP practices from such areas are more likely to only have
one GP and therefore have less time to identify, diagnose and
manage dementia.57 With greater unmet needs,4 people from
deprived areas are more likely to present to emergency healthcare
services later in their disease trajectory when their condition is less
manageable, resulting in poorer management and treatment.
Inequality in primary care provision needs to be addressed, and
promoting earlier identification and diagnosis of dementia needs to
be prioritised as a means to enabling support for PwD in more
disadvantaged areas.
We found evidence of inequalities in care transitions and medi-
cation use between ethnic groups. However, it is important to note
that the inclusion criteria for papers in this review was for papers
that included only people with a formal diagnosis of dementia.
Although people from BAME groups are more likely to have
dementia, they are less likely to be diagnosed14,58 and are therefore
underrepresented in services,59 and may therefore be
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TAB L E 3 Quality rating checklist and applied scores
Author Year
Quality rating checklist pointsa,b
Total Applied checklist points1 2 3 4 5 6 7 8 9 10 11 12 13 14
Aaltonen et al.16 2012 1 1 na 1 0 1 1 1 1 1 1 na na 1 10 11
Calvo‐Perxas et al.19 2014 1 1 na 1 0 na 1 1 1 0 1 na na 1 8 10
Connolly et al.20 2012 1 1 1 1 0 na 1 1 1 0 1 na na 1 9 11
Cooper et al.4 2016 1 1 na 1 0 na 1 1 1 0 1 na na 1 8 10
Cooper et al.12 2017 1 1 na 1 0 na 1 1 1 1 1 na na 1 9 10
Donegan et al.21 2017 0 1 na 1 0 na 1 0 1 0 1 na na 0 5 10
Fillenbaum et al.25 2001 0 1 na 1 0 na 1 1 1 1 1 na na 1 8 10
Huang et al.32 1994 1 1 na 1 0 na 1 0 1 0 1 na na 1 7 10
Johnell et al.33 2013 1 1 na 1 0 na 1 1 1 1 1 na na 1 9 10
Kahle‐Wrobleski et al.34 2017 1 1 na 1 0 1 1 1 1 1 1 na na 0 9 11
Knapp et al.35 2016 1 1 na 1 0 1 1 1 1 0 1 na na 1 9 11
Korhonen et al.36 2018 1 1 na 1 0 na 1 1 1 0 1 na na 1 8 10
Miller et al.37 1998 1 1 na 1 0 1 1 1 1 1 1 na na 0 9 11
Neumann et al.40 2001 1 1 na 1 0 1 1 1 1 0 1 na na 0 8 11
Peterson et al.6 2008 1 1 na 1 0 0 1 0 1 0 1 na na 1 7 11
Pujades‐Rodgriguez et al.41 2018 1 1 na 1 0 0 1 0 1 1 1 na na 0 7 11
Rudolph et al.44 2010 1 1 na 1 0 1 1 0 1 0 1 na na 1 8 11
Scalmana et al.45 2013 1 1 na 1 0 1 1 1 1 0 1 na na 1 9 11
Smith et al.7 2001 1 1 na 1 0 1 1 1 1 1 1 na na 1 10 11
Sommerlad et al.47 2019 1 1 na 1 0 0 1 0 1 0 1 na na 1 7 11
Stevnsborg et al.48 2016 1 1 na 1 0 0 1 0 1 0 1 na na 1 7 11
Taipale et al.49 2014 1 1 na 1 0 0 1 0 1 0 1 na na 1 7 11
Thorpe et al.50 2016 1 1 na 1 0 1 1 na 1 0 1 na na 1 8 10
van de Vorst et al.51 2015 1 1 na 1 0 1 1 na 1 0 1 na na 0 7 10
van de Vorst et al.52 2016 0 1 na 1 0 1 1 1 1 0 1 na na 1 8 11
Verbeek et al.5 2015 1 1 na 1 0 1 1 1 1 1 1 na na 1 10 11
Wattmo et al.55 2013 1 1 na 1 0 1 1 1 1 0 1 na na 1 9 11
Abbreviations: na, not applicable; NIH, National Institutes of Health.
aChecklist points, NIH Quality Assessment Tool for Observational Cohort and Cross‐Sectional Studies: 1. Was the research question or objective in this
paper clearly stated? 2. Was the study population clearly specified and defined? 3. Was the participation rate of eligible persons at least 50%? 4. Were all
the subjects selected or recruited from the same or similar populations (including the same time period)? Were inclusion and exclusion criteria for being
in the study prespecified and applied uniformly to all participants? 5. Was a sample size justification, power description, or variance and effect estimates
provided? 6. For the analyses in this paper, were the exposure(s) of interest measured prior to the outcome(s) being measured? 7. Was the timeframe
sufficient so that one could reasonably expect to see an association between exposure and outcome if it existed? 8. For exposures that can vary in
amount or level, did the study examine different levels of the exposure as related to the outcome (e.g., categories of exposure or exposure measured as
continuous variable)? 9. Were the exposure measures (independent variables) clearly defined, valid, reliable and implemented consistently across all
study participants? 10. Was the exposure(s) assessed more than once over time? 11. Were the outcome measures (dependent variables) clearly defined,
valid, reliable and implemented consistently across all study participants? 12. Were the outcome assessors blinded to the exposure status of
participants? 13. Was loss to follow‐up after baseline 20% or less? 14. Were key potential confounding variables measured and adjusted statistically for
their impact on the relationship between exposure(s) and outcome(s)?
bna, not applicable (point on quality rating was not applicable to the research paper and so was not included in final total or maximum score; 0 ¼ did not
meet criteria, 1 ¼ met criteria).
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underrepresented in the studies included in our review. Diagnosis is a
gateway to accessing care and support, compounding the disadvan-
tage and barriers minority ethnic groups face in diagnosis and
beyond.59–62 Lack of diagnosis leads to poorer care and makes it
more difficult to manage dementia, which our review highlighted.
Poor, inconsistent care results in accelerated disease progression,
increased dependence and shortened lives. These differences
emphasise need for increased awareness of dementia and more
equitable service provision. We also need to better understand how
to provide culturally appropriate services for PwD.
This review highlighted that lower educational attainment
resulted in less care access and poorer survival outcomes. Higher
educational attainment is associated with greater health literacy,
which leads to increased access to both better quality and a wider
breadth of treatment and care.63 People with lower educational
attainment are less likely to know where to go, who to ask, and
what treatment and care is available. They are therefore more likely
to have delayed diagnosis and only receive care once their condi-
tion has worsened, resulting in faster disease progression, greater
interactions with emergency and institutional care, leading to
negative health and social outcomes. More needs to be done to
improve health literacy. Awareness of dementia and the potential
benefits of early diagnosis can help to maintain home care and in-
dependence for longer and provide a better quality of life for PwD
and their carers.
We find that women receive better treatment and require less
urgent care. Although they enter Institutional Long‐Term Care (ILTC)
earlier and use less elective healthcare and social care services, they
tend to have a slower disease trajectory and better outcomes. This
indicates variance in informal care provision and societal, gender‐
based caregiving expectations.64 Women provide more hands‐on
care, experiencing a greater caregiver burden.65,66 With men more
likely to be given care at home for longer,65,66 but more likely to
exhibit more difficult behavioural symptoms,67 a critical point may
come when caring for someone at home becomes too difficult. This is
reflected in greater use of urgent healthcare and later movements to
ILTC for men, and their resultant poorer outcomes.
We have identified older PwD are more likely to live alone. PwD
who live alone, are more often unmarried and older, require more
urgent healthcare, move into ILTC, and have poorer outcomes.
Maintaining independence improves survival, but a lack of informal
care,68,69 greater comorbidities and frailty,70,71 poor prognosis from
elective hospital treatments72 and heightened dementia severity,
lead to older PwD being more likely to spend longer in hospital and
encounter poorer outcomes.73
We find that greater caregiver burden and less support increase
emergency healthcare use and ILTC. PwD in ILTC have poorer
primary healthcare experiences and worse survival. Carers feel a
sense of duty74 and take on great responsibility.75 However, with
substantial caregiver burden, PwD are less likely to use services that
can aid longevity of care at home76 leading to extensive informal
home care becoming unfeasible, resulting in greater ILTC and urgent
healthcare use.
Being able to manage and care for PwD at home is critical to the
sustainability of the health and social care system.8 Lack of informal
care, or having informal caregivers with greater burden, can generate
adverse outcomes for PwD. We have highlighted that both are
factors which differ for men and women with dementia and for older
PwD. Better communication from primary care of what to expect
when providing informal care for PwD, and increased community
care provision77 could reduce caregiver strain, maintain indepen-
dence at home for longer and reduce the need for emergency
healthcare and ILTC. Informal carers need support and those without
it, need to be cared for.
4.1 | Strengths and limitations
To our knowledge, this is the first review to identify inequalities in
dementia care pathways globally through the use of routine data. We
have generated a detailed synthesis of the literature available for
various socio‐economic factors in dementia care pathways. We have
searched multiple evidence bases for available literature and have
assessed the quality of all included papers, judging the value of each
paper based on its quality rating as measured and agreed on by two
research team members.
Some limitations of our review include that we only included
English‐language studies. This may reduce the likelihood of this
review appraising dementia care pathways and inequalities in non‐
English speaking countries, and therefore the generalisability of our
findings to a greater range of geographic settings. In terms of limi-
tations of the included literature, there was limited evidence
comparing countries, potentially reducing generalisability of findings
across geographic areas. Further to this, the majority of studies were
based in the United Kingdom, United States and mainland Europe,
highlighting potential issues with applying findings to other areas,
particularly ‘non‐Western’ countries. While some studies compared
and contrasted different national settings (i.e., Verbeek et al.5), these
were all European countries. Moreover, the majority of studies
investigated only one or two socio‐economic outcomes, with most
evidence on hospital use and ILTC. This highlights the need for
greater research in all aspects of the dementia care pathway. No
single measure is likely to account for the variance in experiences of
PwD. Future research should look to widen the geographic scope and
outcomes considered when investigating dementia care pathways
and inequalities in care for PwD.
5 | CONCLUSIONS AND IMPLICATIONS
This systematic review has identified clear inequalities in current
dementia care pathways across the globe, and the advantages of
using existing routine and cohort data sets to explore and highlight
these. Whilst there is a burgeoning literature on inequalities due to
some socio‐economic factors, there is a dearth of research identifying
the impact of such factors in combination and the specific pathways
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through which they operate. Our findings however are important to
guide the production of improved care plans to ensure that everyone
living with dementia and affected by the condition receives the right
care at the right time. Maintaining care at home is mutually beneficial
and can narrow inequalities but requires informal carers to be sup-
ported—we need to identify ways to reduce carer burden, aid care at
home and improve outcomes as a result. Moreover, there is a need to
provide a more equitable service to PwD, improve the availability of
culturally appropriate services and to provide services to PwD who
are not in the position of being able to call on informal care from
family or friends.
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